Mark H. Ravich is Director at ROCKWELL MEDICAL, INC. (RMTI). They have made 6 open-market trades across 2 companies since 2013, most recently 2025-05-20.
CIK 0000897727
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RMTI | SELL | 2024-11-15 | 2024-11-19 | $2.35 | $70K | -10.8% | -18.3% | -24.3% |
| TIS | SELL | 2015-11-20 | 2016-02-05 | $29.63 | $65K | -7.4% | +5.2% | +16.1% |
| TIS | SELL | 2014-12-09 | 2014-12-10 | $29.15 | $87K | -7.6% | -2.1% | -2.1% |
| TIS | SELL | 2013-11-06 | 2013-11-08 | $30.00 | $255K | -7.6% | -2.1% | -2.1% |
| TIS | SELL | 2013-07-30 | 2013-08-02 | $27.43 | $197K | -7.6% | -2.1% | -2.1% |
| TIS | SELL | 2013-05-24 | 2013-05-29 | $24.10 | $199K | -7.6% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.